Fig. 5. IFN-{alpha} effects on c-myc and Cdc25A expression. Analysis of c-myc and Cdc25A regulation in quiescent (Day 0), PHA-treated (Day 3), IL-2-treated (Days 4–6), and IL-2/IFN-{alpha}-treated (Days 4–6) cells by immunoblotting (A), Northern blot analysis (B), and immunoblotting (C). Tubulin (A and C) and 18S and 28S rRNA (B) served as controls for equal loading.